<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04545801</url>
  </required_header>
  <id_info>
    <org_study_id>ketamine cesarean</org_study_id>
    <nct_id>NCT04545801</nct_id>
  </id_info>
  <brief_title>Ketamine for Analgesia After Cesarean Section</brief_title>
  <official_title>Ketamine for Analgesia After Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mongi Slim Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mongi Slim Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective randomized trial, investigators compared the analgesic effect of&#xD;
      subanesthetic dose of ketamine versus placebo in parturients undergoing cesarean section&#xD;
      under spinal anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective randomized trial, investigators compared the analgesic effect of&#xD;
      subanesthetic dose of ketamine versus placebo in parturients undergoing cesarean section&#xD;
      under spinal anesthesia.&#xD;
&#xD;
      The patients were randomized in two groups:&#xD;
&#xD;
        -  Group Ketamine: these patients recieved 0.25 mg/kg of Ketamin intravenously 5 minutes&#xD;
           after the spinal anesthesia.&#xD;
&#xD;
        -  Group Placebo: recieved 20 ml of normal saline solution intravenously 5 minutes after&#xD;
           the spinal puncture.&#xD;
&#xD;
      The investigators recorded intra demographic, intraoperative and post operative data.&#xD;
&#xD;
      The main outcome was the analgesic score: the visual analog scale (VAS). dynamic VAS was also&#xD;
      monitored at 24 hours post operatively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">April 30, 2019</completion_date>
  <primary_completion_date type="Actual">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dynamic Visual Analog Scale</measure>
    <time_frame>24 hours after cesarean section</time_frame>
    <description>Pain score VAS range from 0 to 10, high scores mean worse outcome</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Cesarean Section</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Ketamine Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients recieving 0.25 mg/kg of ketamine 5 minutes after spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.25 mg/kg of Ketamine</intervention_name>
    <description>patients will recieve 0.25mg/kg of ketamine intravenously 5 min after spinal anesthesia</description>
    <arm_group_label>Ketamine Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>20ml of normal saline solution</intervention_name>
    <description>20ml of normal saline solution intravenously 5 minutes after spinal anesthesia</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  full term pregnant adult patients&#xD;
&#xD;
          -  Monofetal pregnancy&#xD;
&#xD;
          -  scheduled for urgent or elective cesarean section under spinal anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  necessity of general anesthesia during the procedure&#xD;
&#xD;
          -  Post partum hemorrage&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>including only female patients undergoing cesarean section</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mongi Slim University Hospital</name>
      <address>
        <city>La Marsa</city>
        <state>Tunis</state>
        <zip>2046</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 4, 2020</study_first_submitted>
  <study_first_submitted_qc>September 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2020</study_first_posted>
  <last_update_submitted>September 12, 2020</last_update_submitted>
  <last_update_submitted_qc>September 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mongi Slim Hospital</investigator_affiliation>
    <investigator_full_name>Mhamed Sami Mebazaa</investigator_full_name>
    <investigator_title>Professor, head of department of anesthesia and critical care</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

